A bacterial pigment provides cross-species protection from H 2 O 2 - and neutrophil-mediated killing.
Yiwei LiuEleanor A McQuillenPranav S J B RanaErin S GloagMatthew R ParsekDaniel J WozniakPublished in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Bacterial infections are often polymicrobial. Pseudomonas aeruginosa and Staphylococcus aureus cause chronic co-infections, which are more problematic than mono-species infections. Understanding the mechanisms of their interactions is crucial for treating co-infections. Staphyloxanthin (STX), a yellow pigment synthesized by the S. aureus crt operon, promotes S. aureus resistance to oxidative stress and neutrophil-mediated killing. We found that STX production by S. aureus , either as surface-grown macrocolonies or planktonic cultures, was elevated when exposed to the P. aeruginosa exoproduct, 2-heptyl-4-hydroxyquinoline N-oxide (HQNO). This was observed with both mucoid and non-mucoid P. aeruginosa strains. The induction phenotype was found in a majority of P. aeruginosa and S. aureus clinical isolates examined. When subjected to hydrogen peroxide or human neutrophils, P. aeruginosa survival was significantly higher when mixed with wild-type (WT) S. aureus , compared to P. aeruginosa alone or with an S. aureus crt mutant deficient in STX production. In a murine wound model, co-infection with WT S. aureus , but not the STX-deficient mutant, enhanced P. aeruginosa burden and disease compared to mono-infection. In conclusion, we identified a role for P. aeruginosa HQNO mediating polymicrobial interactions with S. aureus by inducing STX production, which consequently promotes resistance to the innate immune effectors H 2 O 2 and neutrophils. These results further our understanding of how different bacterial species cooperatively cause co-infections.
Keyphrases
- wild type
- hydrogen peroxide
- pseudomonas aeruginosa
- oxidative stress
- staphylococcus aureus
- innate immune
- escherichia coli
- cystic fibrosis
- endothelial cells
- dna damage
- cardiac resynchronization therapy
- drug resistant
- left ventricular
- acinetobacter baumannii
- risk factors
- ischemia reperfusion injury
- atrial fibrillation
- methicillin resistant staphylococcus aureus
- heat shock